Ghosh Souradeepa, Chigicherla Krishna Vamshi, Dasgupta Shirin, Goto Yasuyuki, Mukherjee Budhaditya
School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, India.
Dr B C Roy Multispeciality Medical Research Centre, Indian Institute of Technology, Kharagpur, West Bengal, India.
PLoS Pathog. 2025 Jan 31;21(1):e1012858. doi: 10.1371/journal.ppat.1012858. eCollection 2025 Jan.
Despite the withdrawal of pentavalent-antimonials in treating Visceral leishmaniasis from India, recent clinical isolates of Leishmania donovani (LD) exhibit unresponsiveness towards pentavalent-antimony (LD-R). This antimony-unresponsiveness points towards a genetic adaptation that underpins LD-R's evolutionary persistence and dominance over sensitive counterparts (LD-S). This study highlights how LD evolutionarily tackled antimony exposure and gained increased potential of scavenging host-iron within its parasitophorous vacuoles (PV) to support its aggressive proliferation. Even though anti-leishmanial activity of pentavalent antimonials relies on triggering oxidative outburst, LD-R exhibits a surprising strategy of promoting reactive oxygen species (ROS) generation in infected macrophages. An inherent metabolic shift from glycolysis to Pentose Phosphate shunt allows LD-R to withstand elevated ROS by sustaining heightened levels of NADPH. Elevated ROS levels on the other hand trigger excess iron production, and LD-R capitalizes on this surplus iron by selectively reshuffling macrophage-surface iron exporter, Ferroportin, around its PV thereby gaining a survival edge as a heme-auxotroph. Higher iron utilization by LD-R leads to subsequent iron insufficiency, compensated by increased erythrophagocytosis through the breakdown of SIRPα-CD47 surveillance, orchestrated by a complex interplay of two proteases, Furin and ADAM10. Understanding these mechanisms is crucial for managing LD-R-infections and their associated complications like severe anemia, and may also provide valuable mechanistic insights into understanding drug unresponsiveness developed in other intracellular pathogens that rely on host iron.
尽管五价锑剂已不再用于印度内脏利什曼病的治疗,但最近杜氏利什曼原虫(LD)的临床分离株对五价锑(LD-R)表现出无反应性。这种锑无反应性表明存在一种遗传适应性,它支撑着LD-R在进化过程中的持久性以及对敏感菌株(LD-S)的优势地位。本研究强调了LD如何在进化过程中应对锑暴露,并在其寄生泡(PV)内增强清除宿主铁的能力,以支持其快速增殖。尽管五价锑剂的抗利什曼原虫活性依赖于引发氧化爆发,但LD-R在感染的巨噬细胞中展现出一种促进活性氧(ROS)生成的惊人策略。从糖酵解到磷酸戊糖途径的固有代谢转变,使LD-R能够通过维持较高水平的NADPH来抵御升高的ROS。另一方面,升高的ROS水平会触发过量的铁生成,LD-R通过选择性地在其PV周围重新排列巨噬细胞表面的铁输出蛋白铁转运蛋白,利用这种多余的铁,从而作为血红素营养缺陷型获得生存优势。LD-R对铁的更高利用率导致随后的铁缺乏,这通过两种蛋白酶弗林蛋白酶和ADAM10的复杂相互作用,破坏SIRPα-CD47监测,增加红细胞吞噬作用来补偿。了解这些机制对于管理LD-R感染及其相关并发症(如严重贫血)至关重要,也可能为理解其他依赖宿主铁的细胞内病原体产生的药物无反应性提供有价值的机制见解。